New York A 3676: Establishes the Sickle Cell Treatment Act

Status: REFERRED TO HEALTH (as of 2026-01-07)

State: New York · Session: 2025-2026 · Bill: A 3676

Sponsors: Alicia Hyndman, Al Taylor, Albert A. Stirpe, Angelo Santabarbara, Aron Wieder, Brian Cunningham, David Weprin, Jeffrey Dinowitz, Karines Reyes, Larinda Hooks, Maritza Davila, Noah Burroughs, Phil Steck, Rodneyse Bichotte Hermelyn

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A03676 Summary:

BILL NOA03676B

&nbsp

SAME ASSAME AS S01578-B

&nbsp

SPONSORHyndman

&nbsp

COSPNSRSantabarbara, Taylor, Steck, Weprin, Burroughs, Cunningham, Wieder, Davila, Reyes, Bichotte
 Hermelyn, Dinowitz, Hooks, Stirpe

&nbsp

MLTSPNSR

&nbsp

Add §2807-bb, amd §3331, Pub Health L

&nbsp

Establishes the "Sickle Cell Treatment Act" which designates sickle cell centers for excellence and outpatient treatment centers.

Go to top A03676 Actions:

BILL NOA03676B

&nbsp

01/29/2025referred to health

02/05/2025amend and recommit to health

02/05/2025print number 3676a

03/12/2025amend (t) and recommit to health

03/12/2025print number 3676b

01/07/2026referred to health

Go to topA03676 Committee&nbspVotes:

Go to topA03676 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA03676 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 3676--B

 2025-2026 Regular Sessions

 IN ASSEMBLY

 January 29, 2025
 ___________

 Introduced by M. of A. HYNDMAN, SANTABARBARA, TAYLOR, STECK -- read once
 and referred to the Committee on Health -- committee discharged, bill
 amended, ordered reprinted as amended and recommitted to said commit-
 tee -- again reported from said committee with amendments, ordered
 reprinted as amended and recommitted to said committee

 AN ACT to amend the public health law, in relation to establishing the
 "Sickle Cell Treatment Act"

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Short title. This act shall be known and may be cited as
 2 the "Sickle Cell Treatment Act".
 3 § 2. The public health law is amended by adding a new section 2807-bb
 4 to read as follows:
 5 § 2807-bb. Sickle cell centers for excellence and outpatient treatment
 6 centers. 1. Centers for sickle cell care excellence. The commissioner
 7 shall designate five general hospitals or hospices with a minimum of two
 8 centers north of Putnam and Orange counties under article forty of this
 9 chapter, upon successful application, as centers for sickle cell care
 10 excellence. The designations shall be made through an application
 11 designed by the department, and based on service, staffing and other
 12 criteria as developed by the commissioner. The centers of excellence
 13 shall provide specialized sickle cell disease care, treatment, pallia-
 14 tive care, education and related services and shall conduct specialized
 15 research into the care, treatment and management of sickle cell disease.
 16 Designation as a center for sickle cell care excellence shall not enti-
 17 tle a center to enhanced reimbursement, but may be utilized in outreach
 18 and other promotional activities. Each center for sickle cell care
 19 excellence shall affiliate and cooperate with major centers of higher
 20 learning, including medical colleges, and life science research insti-
 21 tutes in the state. The state university shall enter into appropriate
 22 legal agreements to enable this cooperation. Each center for sickle cell

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD01146-06-5

 A. 3676--B 2

 1 care excellence shall receive five hundred thousand dollars per year
 2 from the department, from amounts appropriated for that purpose, to be
 3 used on sickle cell disease research.
 4 2. Outpatient treatment centers. The commissioner shall designate ten
 5 hospitals, distributed based on sickle cell patient population concen-
 6 trations, as sickle cell outpatient treatment centers which shall
 7 provide patients treatment for sickle cell disease as an outpatient.
 8 Each sickle cell outpatient treatment center shall receive two hundred
 9 fifty thousand dollars per year from the department, from amounts appro-
 10 priated for that purpose, to be used to ensure the proper management and
 11 equipping of the centers to care for sickle cell patients.
 12 § 3. Subdivision 8 of section 3331 of the public health law, as added
 13 by section 7-a of part D of chapter 57 of the laws of 2018, is amended
 14 to read as follows:
 15 8. No opioids shall be prescribed to a patient initiating or being
 16 maintained on opioid treatment for pain which has lasted more than three
 17 

View New York A 3676 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.